Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration
Hanna Heloterä1, Kai Kaarniranta1,2
1Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
Abstract:
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the aging population with a limited understanding of its pathogenesis and the number of patients are all the time increasing. AMD is classified into two main forms: dry and neovascular AMD (nAMD). Dry AMD is the most prevalent form (80-90%) of AMD cases. Neovascular AMD (10-20% of AMD cases) is treated with monthly or more sparsely given intravitreal anti-vascular endothelial growth factor inhibitors, but unfortunately, not all patients respond to the current treatments. A clinical hallmark of nAMD is choroidal neovascularization. The progression of AMD is initially characterized by atrophic alterations in the retinal pigment epithelium, as well as the formation of lysosomal lipofuscin and extracellular drusen deposits. Cellular damage caused by chronic oxidative stress, protein aggregation and inflammatory processes may lead to advanced geographic atrophy and/or choroidal neovascularization and fibrosis. Currently, it is not fully known why different AMD phenotypes develop. In this review, we connect angiogenesis and inflammatory regulators in the development of nAMD and discuss therapy challenges and hopes.
Insights
Age-related macular degeneration (AMD) is a growing cause of vision loss. This review explores how blood vessel growth and inflammation contribute to neovascular AMD, seeking new treatment strategies.
Area of Science:
- Ophthalmology
- Pathogenesis of eye diseases
Background:
- Age-related macular degeneration (AMD) is a primary cause of vision impairment in older adults.
- AMD presents as dry or neovascular (wet) forms; neovascular AMD (nAMD) involves choroidal neovascularization.
- Current treatments for nAMD, such as anti-VEGF inhibitors, are not universally effective.
Purpose of the Study:
- To review the pathogenesis of neovascular AMD.
- To explore the roles of angiogenesis and inflammation in nAMD development.
- To discuss current therapeutic challenges and future directions for nAMD.
Main Methods:
- Literature review connecting angiogenesis and inflammatory regulators in nAMD.
- Analysis of AMD pathogenesis, including cellular damage and phenotypic variations.
Main Results:
- AMD progression involves retinal pigment epithelium alterations, lipofuscin, and drusen.
- Oxidative stress, protein aggregation, and inflammation contribute to geographic atrophy and/or choroidal neovascularization.
- The interplay between angiogenesis and inflammation is critical in nAMD development.
Conclusions:
- Understanding the links between angiogenesis and inflammation is key to addressing nAMD.
- Further research is needed to overcome current therapy limitations.
- Developing novel treatments targeting these pathways offers hope for improved nAMD management.
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Inflammatory Response I: Vascular and Cellular
Inflammation
Overview of Cell-Matrix Interactions

